Change in Nfkb/Nrf2/Bax Levels by High Monomeric Polyphenols Berries Extract (HMPBE) in Acute and Chronic Secondary Brain Damage.


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
06 Oct 2024
Historique:
accepted: 17 09 2024
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 7 10 2024
Statut: ppublish

Résumé

High Monomeric Polyphenols Berries Extract (HMPBE) is a formula highly rich in polyphenols clinically proven to enhance learning and memory. It is currently used to enhances cognitive performance including accuracy, working memory and concentration. Here, we investigated for the first time the beneficial effects of HMPBE in a mouse model of acute and chronic traumatic brain injury (TBI). HMPBE, at the dose of 15 mg/kg was able to reduce histological alteration as well as inflammation and lipid peroxidation. HMPBE ameliorate TBI by improving Nrf-2 pathway, reducing Nf-kb nuclear translocation and apoptosis, and ameliorating behavioral alteration such as anxiety and depression. Moreover, in the chronic model of TBI, HMPBE administration restored the decline of Tyrosine Hydroxylase (TH) and dopamine transporter (DAT) and the accumulation of a-synuclein into the midbrain region. This finding correlates the beneficial effect of HMPBE administration with the onset of parkinsonism related to traumatic brain damage. The data may open a window for developing new support strategies to limit the neuroinflammation event of acute and chronic TBI.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
High Monomeric Polyphenols Berries Extract (HMPBE) is a formula highly rich in polyphenols clinically proven to enhance learning and memory. It is currently used to enhances cognitive performance including accuracy, working memory and concentration.
METHODS METHODS
Here, we investigated for the first time the beneficial effects of HMPBE in a mouse model of acute and chronic traumatic brain injury (TBI).
RESULTS RESULTS
HMPBE, at the dose of 15 mg/kg was able to reduce histological alteration as well as inflammation and lipid peroxidation. HMPBE ameliorate TBI by improving Nrf-2 pathway, reducing Nf-kb nuclear translocation and apoptosis, and ameliorating behavioral alteration such as anxiety and depression. Moreover, in the chronic model of TBI, HMPBE administration restored the decline of Tyrosine Hydroxylase (TH) and dopamine transporter (DAT) and the accumulation of a-synuclein into the midbrain region. This finding correlates the beneficial effect of HMPBE administration with the onset of parkinsonism related to traumatic brain damage.
CONCLUSION CONCLUSIONS
The data may open a window for developing new support strategies to limit the neuroinflammation event of acute and chronic TBI.

Identifiants

pubmed: 39370950
doi: 10.33594/000000731
doi:

Substances chimiques

NF-E2-Related Factor 2 0
Polyphenols 0
NF-kappa B 0
Plant Extracts 0
bcl-2-Associated X Protein 0
Tyrosine 3-Monooxygenase EC 1.14.16.2
Dopamine Plasma Membrane Transport Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-570

Subventions

Organisme : University of Catania
ID : MUR PRIN 2022FWB4EX
Pays : Italy
Organisme : Ministry of Education in Saudi Arabia, King Saud University
ID : RSPD2024R750
Pays : Saudi Arabia

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors have no relevant financial or non-financial interests to disclose.

Auteurs

Sergio Modafferi (S)

Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy.

Francesco Molinari (F)

Department of Veterinary Sciences, University of Messina, Viale SS Annunziata, 98168 Messina, Italy.

Livia Interdonato (L)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Viale F. Stagno D'Alcontres 31, 98166 Italy.

Roberta Fusco (R)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Viale F. Stagno D'Alcontres 31, 98166 Italy.

Daniela Impellizzeri (D)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Viale F. Stagno D'Alcontres 31, 98166 Italy.

Rosalba Siracusa (R)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Viale F. Stagno D'Alcontres 31, 98166 Italy.

Ramona D'Amico (R)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Viale F. Stagno D'Alcontres 31, 98166 Italy.

Ali S Abdelhameed (AS)

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, King-dom of Saudi Arabia.

Uwe Wenzel (U)

Institut für Ernährungswissenschaft, Justus Liebig Universitat Giessen, 35390 Giessen, Germany.

Ursula Jacobs (U)

System Biologie AG · Sihleggstrasse 23. CH-8832 Wollerau Switzerland.

Tilman Fritsch (T)

NAM-Institute, Salzburg, Salzburg, A-5020, Austria.

Naomi Osakabe (N)

Department of Bio-science and Engineering, Faculty of System Science and Engineering, Shibaura Institute of Technology, Japan.

Salvatore Cuzzocrea (S)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Viale F. Stagno D'Alcontres 31, 98166 Italy.

Vittorio Calabrese (V)

Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy.

Rosanna Di Paola (RD)

Department of Veterinary Sciences, University of Messina, Viale SS Annunziata, 98168 Messina, Italy, dipaolar@unime.it.

Marika Cordaro (M)

Department of Biomedical, Dental and Morphological and Functional Imaging University of Messina, Via Consolare Valeria, 98125 Messina, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH